Henry Schein, Inc. (HSIC) Position Lifted by Quantum Capital Management LLC NJ
Quantum Capital Management LLC NJ increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 10.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 129,178 shares of the company’s stock after buying an additional 12,504 shares during the period. Henry Schein comprises approximately 2.8% of Quantum Capital Management LLC NJ’s holdings, making the stock its 14th largest position. Quantum Capital Management LLC NJ’s holdings in Henry Schein were worth $9,383,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Squar Milner Financial Services LLC bought a new position in Henry Schein in the 2nd quarter worth $120,000. Piedmont Investment Advisors LLC bought a new position in Henry Schein in the 2nd quarter worth $130,000. Fuller & Thaler Asset Management Inc. boosted its holdings in Henry Schein by 57.1% in the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after buying an additional 800 shares during the period. BerganKDV Wealth Management LLC bought a new position in Henry Schein in the 2nd quarter worth $203,000. Finally, Quest Investment Management LLC bought a new position in Henry Schein in the 2nd quarter worth $214,000. 96.65% of the stock is owned by institutional investors.
HSIC stock traded down $0.16 during mid-day trading on Friday, hitting $76.84. The company had a trading volume of 3,474 shares, compared to its average volume of 1,267,116. The stock has a market cap of $12.36 billion, a P/E ratio of 21.37, a PEG ratio of 2.31 and a beta of 1.00. Henry Schein, Inc. has a 12-month low of $62.56 and a 12-month high of $89.34. The company has a quick ratio of 0.68, a current ratio of 1.29 and a debt-to-equity ratio of 0.34.
Several research analysts recently weighed in on HSIC shares. Barclays reaffirmed a “hold” rating and issued a $73.00 target price on shares of Henry Schein in a report on Wednesday, May 9th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, May 10th. Barrington Research dropped their target price on shares of Henry Schein to $88.00 and set an “outperform” rating for the company in a report on Thursday, May 10th. TheStreet raised shares of Henry Schein from a “c” rating to a “b-” rating in a report on Monday, May 14th. Finally, BidaskClub raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday, June 13th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $84.11.
In other news, Director Paul Brons sold 4,822 shares of the company’s stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $72.93, for a total transaction of $351,668.46. Following the sale, the director now directly owns 20,889 shares in the company, valued at approximately $1,523,434.77. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Mark E. Mlotek sold 10,359 shares of the company’s stock in a transaction dated Tuesday, June 12th. The shares were sold at an average price of $72.73, for a total transaction of $753,410.07. Following the sale, the executive vice president now owns 79,506 shares in the company, valued at $5,782,471.38. The disclosure for this sale can be found here. 1.15% of the stock is owned by insiders.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: Penny Stocks, What You Need To Know
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.